Series B - Microbiotica

Series B - Microbiotica

Investment Firm

Overview

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

Announced Date

Feb 07, 2022

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorBritish Patient Capital
Participant InvestorCambridge Innovation Capital
Participant InvestorFlerie Invest
Participant InvestorIP Group
Participant InvestorSeventure Partners

Round Details and Background

Microbiotica raised $67685102 on 2022-02-07 in Series B

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 24, 2018
Venture Round - Microbiotica
1-5.2M
Feb 07, 2022
Series B - Microbiotica
6-67.7M
Dec 19, 2016
Seed Round - Microbiotica
2-9.9M

Recent Activity

There is no recent news or activity for this profile.